Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)

Molecular Psychiatry

Volumn 5, Issue 3, 2000, Pages 275-282

  Grunhage F ^a   Schulze, T G ^a   Muller D J ^a   Lanczik, M ^b   Franzek, E ^b   Albus, M ^c   Borrmann Hassenbach, M ^c   Knapp, M ^a   Cichon, S ^a   Maier, W ^a   Rietschel, M ^a   Propping, P ^a   Nothen M M ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c KLINIKUM MÜNCHEN OST   (Germany)

Author keywords

Bipolar affective disorder; Candidate gene; Genetic variation; Manic depression; Mutation; Single nucleotide polymorphism

Indexed keywords

ALANINE; DOPAMINE TRANSPORTER; GLUTAMIC ACID; GLYCINE; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DOPAMINERGIC TRANSMISSION; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC CONSERVATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INTRON; MALE; MANIC DEPRESSIVE PSYCHOSIS; MISSENSE MUTATION; NEUROPSYCHIATRY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0033946739     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000711     Document Type: Article

References (44)

1. 1 Uhl GR. Neurotransmitter (plus): a promising gene family. Trends Neurosci 1992; 15: 265-268.
2. 2 Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci 1993; 16: 73-93.
3. 3 Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 1993; 14: 43-49.
4. 4 Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237: 1219-1223.
5. 5 Ritz MC, Kuhar MJ. Psychostimulant drugs and a dopamine hypothesis regarding addiction: an update on recent research. Biochem Soc Symp 1993; 59: 51-64.
6. 6 Kitayama S, Wang J-B, Uhl GR. Dopamine transporter mutants selectively enhance MPP* transport. Synapse 1993; 15: 58-62.
7. 7 Edvardsen O, Dahl SG. A putative model of the dopamine transporter. Mol Brain Res 1994; 27: 265-274.
8. 8 Giros B, El Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 1992; 42: 383-390.
9. 9 Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Wang Jabs E et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14: 1104-1106.
10. 10 Vandenbergh DJ, Persico AM, Uhl GR. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element, and provides racially dimorphic TaqI RFLPs. Mol Brain Res 1992; 15: 161-166.
11. 11 Byerley W, Hoff M, Holik J, Caron MG, Giros BG. VNTR polymorphism for the human dopamine transporter gene (DAT1). Hum Mol Genet 1993; 2: 335.
12. 12 Sano A, Kondoh K, Kakimoto Y, Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 1993; 91: 405-406.
13. 13 Kawarai T, Kawakami H, Yamamura Y, Nakamura S. Structure and organization of the gene encoding human dopamine transporter. Gene 1997; 195: 11-18.
14. 14 Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-998.
15. 15 Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and dopamine transporter polymorphism. Mol Psychiatry 1997; 2: 311-313.
16. 16 Waldman ID, Rowe DG, Abramowitz A, Kozel ST, Mohr JH, Sherman SL et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtypes and severity. Am J Hum Genet 1998; 63: 1767-1776.
17. 17 Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999; 4: 192-196.
18. 18 Waldman ID, Robinson BF, Feigon SA. Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity. Genet Epidemiol 1997; 14: 699-704.
19. 2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol Psychiatry 1997; 2: 239-246.
20. 20 Gelernter J, Kranzler HR, Satel SL, Rao PA. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 1994; 11: 195-200.
21. 21 Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 1997; 41: 299-304.
22. 22 Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 1998; 155: 474-478.
23. 23 Gelernter J, Kranzler H, Lacobelle J. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3). apolipoprotein E (APOE). μ opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). Genomics 1998; 52: 289-297.
24. 24 Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837-844.
25. 25 American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn revised. American Psychiatric Association Press: Washington DC, 1987.
26. 26 Mannuzza S, Fyer AJ, Endicott J, Klein DF. Family Informant Schedule and Criteria (FISC). Anxiety Disorders Clinic, New York State Psychiatric Institute: New York, 1985.
27. 27 Donovan DM, Vandenbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E et al. GR. Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures. Mol Brain Res 1995; 30: 327-335.
28. 28 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
29. 29 Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus D1S80 by the PCR followed by high resolution PAGE. Am J Hum Genet 1991; 48: 137-144.
30. 30 Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49-67.
31. 31 Terwilliger JD, Ott J. Handbook of Human Genetic Linkage. Johns Hopkins University Press: Baltimore, 1994.
32. 32 Shapiro M, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and fundamental implications in gene expression. Nucleic Acids Res 1987; 15: 7155-7174.
33. 33 Kelsoe JR, Dessa Sadovnick A, Kristbjarnarson H, Bergesch P, Mroczkowski-Parker Z, Drennan M et al. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet 1996; 67: 533-540.
34. 34 Homer JP, Flodman PM, Spence MA. Bipolar disorder: dominant or recessive on chromosome 5? Genet Epidemiol 1997; 14: 647-651.
35. 35 Souery D, Lipp O, Mahieu B, Mendelbaum K, De Martelaer V, Van Broeckhovon C et al. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. Am J Med Genet 1996; 67: 551-555.
36. 36 Gomez-Casero E, Perez de Castro I, Saiz-Ruiz J, Llinares C, Fernandez-Piqueras J. No association between particular DRD3 and DAT gene polymorphisms and manic-depressive illness in a Spanish sample. Psychiatr Genet 1996; 6: 209-212.
37. 37 Manki H, Kanba S, Muramatsu T, Higuchi S, Suzuki E, Matsushita S et al. Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. J Affect Disord 1996; 40: 7-13.
38. 38 Lee FJS, Pristupa ZB, Ciliax BJ, Levey AI, Niznik HB. The dopamine transporter carboxyl-terminal tail. J Biol Chem 1996; 271: 20885-20894.
39. 39 Lesch KP, Gross J, Franzek E, Wolozin BL, Riederer P, Murphy DL. Primary structure of the serotonin transporter in unipolar depression and bipolar disorder. Biol Psychiatry 1995; 37: 215-223.
40. 40 Di Bella D, Catalano M, Balling U, Smeraldi E, Lesch KP. Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE. Am J Med Genet 1996; 67: 541-545.
41. 41 Stöber G, Nöthen MM, Pörzgen P, Brüss M, Bönisch H, Knapp M et al. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 1996; 67: 523-532.
42. 42 Stöber G, Hebebrand J, Cichon S, Brüss M, Bönisch H, Lehmkuhl G et al. Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening. Am J Med Genet 1999; 88: 158-163.
43. 43 Heils A, Teufel A, Petri S, Stöber G, Bengel B, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 6: 2612-2624.
44. 44 Kouzmenko AP, Pereira AM, Singh BS. Intronic sequences are involved in neural targeting of human dopamine transporter gene expression. Biochem Biophys Res Commun 1997; 240: 807-811.